NEWTON, Mass.--(BUSINESS WIRE)--Nov. 18, 2005--Clinical Data, Inc. (NASDAQ:CLDA) today announced that it has entered into definitive agreements with certain institutional and other accredited investors with respect to the private placement of 614,629 shares of newly issued common stock, and warrants to purchase 307,315 shares of common stock, for a total purchase price of approximately $12.025 million. The Company intends to use the gross proceeds from the private placement, which will be paid in full to the Company as no placement agent was used in the transaction, to pay down certain outstanding indebtedness and to support the Company's growth plans as it continues to integrate the operations of Genaissance Pharmaceuticals and plan for the acquisition of Icoria, Inc., which is expected to close in mid December.
